Clinical trial
Multi-Center, Randomized, Open-Label, Parallel Group Study of a Vaginal…
NCT00296478 · Ferring Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00296478 |
|---|---|
| Title | Multi-Center, Randomized, Open-Label, Parallel Group Study of a Vaginal Micronized Progesterone Tablet (Endometrin®) Compared to Crinone 8% Vaginal Gel in Female Patients Undergoing In-Vitro Fertilization (IVF) |
| Official title | Multi-Center, Randomized, Open-Label, Parallel Group Study of a Vaginal Micronized Progesterone Tablet (Endometrin®) Compared to Crinone 8% Vaginal Gel in Female Patients Undergoing In-Vitro Fertilization (IVF) |
| Lead sponsor | Ferring Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Fertility |
| Intervention type | Drug |
| Interventions | Endometrin, Crinone |
| Enrollment | 1,211 |
| Start date | Jul 1, 2005 |
| Primary completion | Apr 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Feb 27, 2006 |
| Last update posted | May 19, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: